Childhood cancers: open trials in Finland

39 open trials have a site in Finland. Registry data; only the trial team decides who can take part.

NCT03435796
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Trial Treatment · Phase 2/3 · Celgene
HUS Helsinki University Hospital, Helsinki · Pohjois-Pohjanmaan hyvinvointialue, Oulu · Varsinais-Suomen hyvinvointialue, Turku
Registry updated 2026-11-02
NCT07476729
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
Trial Treatment · Phase 3 · Charite University, Berlin, Germany
HUS-Yhtymae, Helsinki · Kuopio University Hospital, Kuopio · Oulu University Hospital, Oulu · Tampere University Hospital, Tampere · Turku University Hospital, Turku
Registry updated 2026-10-26
NCT07871864
Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
Trial Treatment · Phase 3 · Gustave Roussy, Cancer Campus, Grand Paris
HUS-Yhtymae, Helsinki · HUS-Yhtymae, Medical treatment and Clini-cal trial units, Helsinki · Pohjois-Savon hyvinvointialue, Kuopio · Pohjois-Pohjanmaan hyvinvointialue, Oulu · Pirkanmaan hyvinvointialue, Tampere · Varsinais-Suomen hyvinvointialue, Turku
Registry updated 2026-10-26
2022-501454-11-00
International study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of Vinblastine
Trial Treatment · Phase 3 · GPOH gGmbH
HUS Helsinki University Hospital, Helsinki · Pohjois-Savon hyvinvointialue, Kuopio · Oulu University Hospital, Oulu · Tampere University Hospital, Tampere · Turku University Hospital, Turku
Registry updated 2026-10-21
NCT05476939
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0
Trial Treatment · Phase 3 · Gustave Roussy, Cancer Campus, Grand Paris
HUS-Yhtymae, Helsinki · Pohjois-Savon hyvinvointialue, Kuopio · Pohjois-Pohjanmaan hyvinvointialue, Oulu · Pirkanmaan hyvinvointialue, Tampere · Varsinais-Suomen hyvinvointialue, Turku
Registry updated 2026-10-21
NCT07297914
Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL
Trial Treatment · Phase 2/3 · Bambino Gesù Hospital and Research Institute
HUS-Yhtymae (HUS Helsinki University Hospital), Helsinki
Registry updated 2026-10-20
2022-501180-40-00
International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma
Trial Treatment · Phase 3 · GPOH gGmbH
HUS Helsinki University Hospital, Helsinki · Kuopio University Hospital, Kuopio · Oulu University Hospital, Oulu · Tampere University Hospital, Tampere · Turku University Hospital, Turku
Registry updated 2026-10-19
NCT05327894
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Trial Treatment · Phase 3 · Princess Maxima Center for Pediatric Oncology
HUS, Helsinki · Kuopio University Hospital, Kuopio · Oulu University Hospital, Oulu · TAYS Sydaenkeskus Oy, Tampere · University Of Turku, Turku
Registry updated 2026-10-19
NCT06697301
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Trial Treatment · Phase 2/3 · Eikon Therapeutics
HUS-Yhtymae, Helsinki · Pohjois-Savon hyvinvointialue, Kuopio · Oulu University Hospital, Oulu · Tampere University Hospital, Tampere
Registry updated 2026-10-06
NCT05748171
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
Trial Treatment · Phase 2 · Pfizer
HUS-Yhtymae, Helsinki
Registry updated 2026-09-24
2023-504999-25-00
CHIP-AML22 Master protocol: Protocol for the treatment of children and adolescents with Acute Myeloid Leukemia (AML)
Trial Treatment · Phase 3 · Prinses Maxima Centrum voor Kinderoncologie B.V.
HUS-Yhtymae, Helsinki · Pohjois-Savon hyvinvointialue, Kuopio · Oulu University Hospital, Oulu · Pirkanmaan hyvinvointialue, Tampere · Turku University Hospital, Turku
Registry updated 2026-09-23
NCT07679269
Roll-Over Study of Alpelisib (BYL719) for Continued Access and Long-Term Safety.
Trial Treatment · Phase 2 · Novartis Pharmaceuticals
Tampere University Hospital, Tampere
Registry updated 2026-09-18
2022-501456-28-00
An international trial for children with atypical teratoid/rhabdoid tumours (ATRT)
Trial Treatment · Phase 3 · GPOH gGmbH
HUS-Yhtymae, Helsinki · Kuopio University Hospital, Kuopio · Oulu University Hospital, Oulu · Tampere University Hospital, Tampere · Turku University Hospital, Turku
Registry updated 2026-09-14
2024-510578-25-00
SIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years.
Trial Treatment · Phase 3 · The University Of Birmingham
HUS-Yhtymae, Helsinki · Pohjois-Savon hyvinvointialue, Kuopio · Pohjois-Pohjanmaan hyvinvointialue, Oulu · Pirkanmaan hyvinvointialue, Tampere · Varsinais-Suomen hyvinvointialue, Turku
Registry updated 2026-09-04
NCT01949129
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Trial Treatment · Phase 2/3 · St. Anna Kinderkrebsforschung
Division of Hematology-Oncology and Stem Cell Transplantation, Hospital for Children and Adolescents, Univ. of Helsinki, Helsinki
Registry updated 2026-09-04
NCT07778173
Three-Dimensional Molds Based on Radiological imagEs in Patients With Cancer: the DIRECT Trial
Trial Treatment · Tampere University Hospital
Tampere University Hospital, Tampere
Registry updated 2026-08-21
NCT03911128
A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Research · Mats Heyman
Helsinki University Hospital, Dept of Haematology, Helsinki · Helsinki University Hospital, Dept of Paediatrics, Helsinki · Kuopio University Hospital, Dept of Paediatrics, Kuopio · Kuopio University Hospital, Dept of Haematology, Kuopio · Oulu University Hospital, Dept of Haematology, Dept of Medicine, Oulu · Oulu University Hospital, Dept of Paediatrics, Oulu · Tampere University Hospital, Dept of Paediatrics, Tampere · Tampere University Hospital, Dept of Haematology, Tampere · Turku University Hospital, Dept of Paediatrics, Turku · Turku University Hospital, Clinical Haematology and Stem Cell Transplantation Unit, Turku
Registry updated 2026-08-13
NCT02300766
Cerebellar Mutism Syndrome Study
Research · Copenhagen University Hospital, Rigshospitalet
Helsinki University Central Hospital, Helsinki · Kuopio University Hospital, Kuopio · Oulu University Hospital, Oulu · Tampere University Hospital, Tampere · Turku University Hospital, Turku
Registry updated 2026-08-12
NCT04307576
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Trial Treatment · Phase 3 · Mats Heyman
HUS-Yhtymae, Helsinki · Pohjois-Savon hyvinvointialue, Kuopio · Pohjois-Pohjanmaan hyvinvointialue, Oulu · Pirkanmaan hyvinvointialue, Tampere · Varsinais-Suomen hyvinvointialue, Turku
Registry updated 2026-08-12
NCT07740239
A COhort Study on Factors Leading to Vulnerability in Adult Patients With Serious Medical cOnditionS: the COSMOS-I Trial
Research · Tampere University Hospital
Tampere University Hospital, Tampere
Registry updated 2026-07-31
2023-505575-69-01
Fight Osteosarcoma Through European Research evolving study platform from diagnosis to relapse (FOSTER evolving study platform)
Trial Treatment · Phase 3 · Institut Gustave Roussy
HUS-Yhtymae, Helsinki · Pohjois-Savon hyvinvointialue, Kuopio · Pohjois-Pohjanmaan hyvinvointialue, Oulu · Pirkanmaan hyvinvointialue, Tampere · Varsinais-Suomen hyvinvointialue, Turku
Registry updated 2026-07-13
NCT02265770
SIOP Ependymoma II: An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with ependymoma
Trial Treatment · Phase 2/3 · Centre Leon Berard
HUS-Yhtymae, Helsinki · Pohjois-Savon hyvinvointialue, Kuopio · Oulu University Hospital, Oulu · Pirkanmaan hyvinvointialue, Tampere · Varsinais-Suomen hyvinvointialue, Turku
Registry updated 2026-06-10
2025-520982-39-00
Study on chemotherapy and experimental drugs in patients with Philadelphia Chromosome positive and ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia
Trial Treatment · Phase 3 · Universita Degli Studi Di Milano Bicocca
New Children’s Hospital, Helskinki University Hospital, Helsinki · Kuopio University Hospital, Kuopio · Oulu University Hospital, Oulu · Tampere University Hospital, Tampere · Turku University Hospital, Turku
Registry updated 2026-05-08
2023-504880-18-00
A phase 1B of crizotinib either in combination or as single agent in pediatric patients with ALK, ROS1 or MET positive malignancies
Trial Treatment · Phase 1/2 · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
HUS-Yhtymae, Helsinki
Registry updated 2026-05-07
NCT04043494
International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
Trial Treatment · Phase 3 · University Hospital Muenster
HUS-Yhtymae, Helsinki · Pohjois-Savon hyvinvointialue, Kuopio · Oulu University Hospital, Oulu · Tampere University Hospital, Tampere · Turku University Hospital, Turku
Registry updated 2026-05-06

All Childhood cancers trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error